Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach.
about
Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumorsLanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine TumorsElucidating the role of disulfide bond on amyloid formation and fibril reversibility of somatostatin-14: relevance to its storage and secretionControl of peptide nanotube diameter by chemical modifications of an aromatic residue involved in a single close contact.Cyclic N-terminal loop of amylin forms non amyloid fibers.Pharmacokinetic evaluation of lanreotide.Using small angle scattering (SAS) to structurally characterise peptide and protein self-assembled materials.Peptide and protein-based nanotubes for nanobiotechnology.The place of medical treatment of acromegaly: current status and perspectives.Lanreotide autogel in acromegaly - a decade on.Challenges in the delivery of peptide drugs: an industry perspective.Atomic view of the histidine environment stabilizing higher-pH conformations of pH-dependent proteins.Protein attributes contribute to halo-stability, bioinformatics approach.Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.Fibril-mediated oligomerization of pilin-derived protein nanotubes.Low concentration structural dynamics of lanreotide and somatostatin-14Directing peptide crystallization through curvature control of nanotubes
P2860
Q28069632-FFCB0DA8-7F82-4232-897B-37A53BFB74ABQ28071569-7C956603-43A9-49A6-9D39-55C3BA802C88Q33761231-DC0B70A6-C8D3-4341-A6E8-F63F7B6038E7Q33881743-E0BF877C-E6CF-468D-B479-BF39FB3BAE5EQ37217168-48F113E8-C6B4-426A-B7CA-5A9806BF81B8Q37780553-F7714C90-15EA-4755-A2E0-3549A3D2CD96Q37813034-DC2A0C5C-9BC9-4F33-BBC1-2AB84A7C02E5Q38023314-2CEE1C75-67A8-45AA-AE46-C749CC7237C1Q38100275-8C283BB5-F565-4F36-9F3A-179A444F48B6Q38259409-9444389B-E6E6-4B4D-9D94-F19CCA1DD09EQ38358860-79AD3C8C-7FB8-45E8-A65C-CAE4518306A3Q41571161-05EF1508-1EF0-4E71-A517-90FD60247BD2Q42130278-C61FFFC7-09EB-400F-B1C2-D5FFD731FEB1Q43078115-5740779B-5EDF-4A5A-8536-555BC5A13609Q43101912-7B2CDDC7-F70E-4BB7-8420-AD6E2433D455Q57162634-DC069BE4-D44F-4E29-9B3B-75EBDB22945BQ57163549-F9A57F44-E291-4EC4-88AB-122820C46728
P2860
Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Molecular origin of the self-a ...... otubes: a mutational approach.
@ast
Molecular origin of the self-a ...... otubes: a mutational approach.
@en
type
label
Molecular origin of the self-a ...... otubes: a mutational approach.
@ast
Molecular origin of the self-a ...... otubes: a mutational approach.
@en
prefLabel
Molecular origin of the self-a ...... otubes: a mutational approach.
@ast
Molecular origin of the self-a ...... otubes: a mutational approach.
@en
P2093
P2860
P50
P1433
P1476
Molecular origin of the self-a ...... otubes: a mutational approach.
@en
P2093
Anjali Pandit
Céline Valéry
Franck Artzner
Isabelle Boisdé
Jean-Marc Verbavatz
Luc Bordes
Maité Paternostre
Roland Cherif-Cheikh
P2860
P304
P356
10.1529/BIOPHYSJ.107.108175
P407
P577
2007-11-09T00:00:00Z